Diabetic patients and individuals treated with bisphosphonates represent a significant portion of the population. The number of these patients continues to increase. Periodontal disease has been found to be a complication of diabetes and a risk of poor diabetic control. Over the years, the direct correlation of diabetic control and tooth loss has been difficult to assess. In addition, the diabetic periodontal patient has a greater prevalence of tooth loss and often elective dental implant treatment. Recently, patients using bisphosphonates have become a concern because of the development of osteonecrosis of the jaw. Patient that suffer this complication can be difficult to treat and may become disfigured. Guidelines for the treatment of patients with diabetes as well as those who have been treated with bisphosphonates continue to evolve.
Joseph P. Fiorellini, DMD, DMSc, is program director of the Department of Periodontology at the University of Pennsylvania School of Dental Medicine. He serves on the editorial boards of the Journal of Periodontology and The International Journal of Periodontics & Restorative Dentistry and was the 1994 recipient of the American Academy of Periodontology’s Young Investigator Award. Dr Fiorellini’s areas of research include wound healing around endosseous implant materials, systemic illness, treatment of failing implants, and periodontal diagnostics.
Approximate Running Time: 45 minutes